Education
About Us
Working with TipRanks
Follow Us
Biogen (IT:1BIIB)
:1BIIB
1BIIB Analyst Ratings
Moderate Buy
14 Buy
16 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
1BIIB Stock 12 Month Forecast
Average Price Target
€150.81
▲(43.09% Upside)
| Highest Price Target€231.04 | Average Price Target€150.81 | Lowest Price Target€102.19 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Best Analysts Covering Biogen
Which Analyst Should I Follow If I Want to Buy IT:1BIIB and Sell After:
1 Month
xxx
Success Rate
16/34 ratings generated profit
Average Return
+0.15%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 47.06% of your transactions generating a profit, with an average return of +0.15% per trade.
3 Months
xxx
Success Rate
16/34 ratings generated profit
Average Return
-2.00%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 47.06% of your transactions generating a profit, with an average return of -2.00% per trade.
1 Year
Success Rate
8/32 ratings generated profit
Average Return
-13.78%
reiterated a buy rating 12 days ago
Copying Brian Abrahams's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -13.78% per trade.
2 Years
xxx
Success Rate
10/38 ratings generated profit
Average Return
-22.24%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 26.32% of your transactions generating a profit, with an average return of -22.24% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
1BIIB Analyst Recommendation Trends
Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
9
13
12
14
12
Buy
3
6
8
8
6
Hold
21
28
25
32
22
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
33
47
45
54
40
Each month's total comprises the sum of three months' worth of ratings.
1BIIB Financial Forecast
1BIIB Stock Forecast FAQ
What is IT:1BIIB’s average 12-month price target, according to analysts?
Based on analyst ratings, Biogen’s 12-month average price target is 150.81.
What is IT:1BIIB’s upside potential, based on the analysts’ average price target?
Biogen has 43.09% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Biogen a Buy, Sell or Hold?
Biogen has a consensus rating of Moderate Buy, which is based on 14 buy ratings, 16 hold ratings and 0 sell ratings.
What is Biogen’s share price target?
The average share price target for Biogen is 150.81. This is based on 30 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €231.04 ,and the lowest forecast is €102.19. The average share price target represents 43.09% Increase from the current price of €105.4.
The highest analyst share price target is €231.04 ,and the lowest forecast is €102.19. The average share price target represents 43.09% Increase from the current price of €105.4.
What do analysts say about Biogen?
Biogen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 30 Wall Streets Analysts.
How can I buy shares of Biogen?
To buy shares of IT:1BIIB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.